Expression of TieDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 does not significantly alter the protrusion and retraction morphodynamics in border cell cluster migration.
Expression of TieDN.Scer\UAS under the control of Scer\GAL4c306 does not result in defects in border follicle cell migration.
EgfrDN.UAS, PvrDN.UASp, Scer\GAL4slbo.2.6, TieDN.UAS has abnormal cell migration phenotype
TieDN.UAS, Scer\GAL4slbo.2.6 is an enhancer of border follicle cell phenotype of PvrDN.UASp, Scer\GAL4slbo.2.6
TieDN.UAS, Scer\GAL4slbo.2.6 is an enhancer of border follicle cell phenotype of EgfrDN.UAS, PvrDN.UASp, Scer\GAL4slbo.2.6
EgfrDN.UAS, PvrDN.UASp, Scer\GAL4slbo.2.6, TieDN.UAS has border follicle cell phenotype
The addition of a dominant-negative TieDN.Scer\UAS to border cells expressing PvrDN.Scer\UAS and EgfrDN.Scer\UAS alters the protrusion and retraction morphodynamics of border cell cluster migration.
Co-expression of TieDN.Scer\UAS enhances the border cell migration defects caused by expression of PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6, such that 37-58% of stage 10 egg chambers show border cell migration defects.
Co-expression of PvrDN.Scer\UAS and EgfrDN.Scer\UAS under the control of Scer\GAL4c306 results in border cell migration defects. The severity of the migration defects is enhanced if the females also express TieDN.Scer\UAS.